The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study (Q35038525)

5 August 2017

title

The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study (English)

1 reference

5 August 2017

1 reference

Tsuyoshi Ohkura

1

1 reference

5 August 2017

Kazuoki Inoue

2

1 reference

5 August 2017

Youhei Fujioka

3

1 reference

5 August 2017

Risa Nakanishi

4

1 reference

5 August 2017

Hideki Shiochi

5

1 reference

5 August 2017

Keisuke Sumi

6

1 reference

5 August 2017

Naoya Yamamoto

7

1 reference

5 August 2017

Kazuhiko Matsuzawa

8

1 reference

5 August 2017

Shoichiro Izawa

9

1 reference

5 August 2017

Hiroko Ohkura

10

1 reference

5 August 2017

Masahiko Kato

11

1 reference

5 August 2017

Kazuhiro Yamamoto

12

1 reference

5 August 2017

Shin-ichi Taniguchi

13

1 reference

5 August 2017

publication date

11 November 2013

1 reference

5 August 2017

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

page(s)

453

1 reference

Creative Commons Attribution 2.0 Generic

5 August 2017

copyright license

start time

11 November 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Hyperinsulinaetmia of Hypertriglyceridaemia: A Reappraisal

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Chronic sulfonylurea treatment and hyperglycemia aggravate disproportionately elevated plasma proinsulin levels in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-6-453

Sulfonylurea induced beta-cell apoptosis in cultured human islets

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Risk factors for worsening to diabetes in subjects with impaired glucose tolerance

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3829708

Risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japan

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24215809

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term effects of glibenclamide and nateglinide upon pancreatic islet function in normal and diabetic rats

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24215809

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1756-0500-6-453

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference